from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2978c/-

LFCtreatmentdescriptionclass of inhibitor

-0.771

Amikacinug/mL Amikacintranslation

-0.543

Cap5-10ug/mL Capreomycintranslation

-0.723

Rox10-50 ug/mL Roxithromycintranslation

-0.526

SM2-5 ug/mL Streptomycintranslation

-0.745

Tet5-10 ug/mL Tetracyclinetranslation

-0.560

Rif0.2-5ug/mL Rifampicintranscription

-0.954

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.116

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.303

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.227

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.100

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.026

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.104

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.384

Nigericin50 uM Nigericinrespiration

-0.022

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.000

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

0.091

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.287

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.361

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.689

NRP_1Non-replicating persistence stage 1dosRassociated

-0.748

Amp0.2mg/mL AmpicillincellWall

-0.291

Cephalexin20-100 ug/mL CephalexincellWall

-0.131

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.128

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.734

EMB10-20 ug/mL EthambutolcellWall

-0.789

Eta12-40 ug/mL EthionamidecellWall

-1.043

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.565

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.332

BZA0.12 mg/mL BenzamidearomaticAmides

-0.052

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.104

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.760

H2O24 mM hydrogen peroxideDNAdamaging

2.976

Levo10 ug/mL LevofloxacinDNAdamaging

0.558

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.357

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.798

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.133

Antimycin12.5-50 ug/mL Antimycin A?

0.968

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.147

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.621

PA8240.2-2 ug/mL PA-824?

0.422

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.168

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?